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Background: Online cancer information can support patients in making treatment decisions. However, such
information may not be adequately tailored to the patient’s perspective, particularly if healthcare professionals do
not sufficiently engage patient groups when developing online information. We applied qualitative user testing
during the development of a patient information website on stereotactic ablative radiotherapy (SABR), a new
guideline-recommended curative treatment for early-stage lung cancer.
Methods: We recruited 27 participants who included patients referred for SABR and their relatives. A qualitative
user test of the website was performed in 18 subjects, followed by an additional evaluation by users after website
redesign (N = 9). We primarily used the ‘thinking aloud’ approach and semi-structured interviewing. Qualitative data
analysis was performed to assess the main findings reported by the participants.
Results: Study participants preferred receiving different information that had been provided initially. Problems
identified with the online information related to comprehending medical terminology, understanding the scientific
evidence regarding SABR, and appreciating the side-effects associated with SABR. Following redesign of the
website, participants reported fewer problems with understanding content, and some additional recommendations
for better online information were identified.
Conclusions: Our findings indicate that input from patients and their relatives allows for a more comprehensive and
usable website for providing treatment information. Such a website can facilitate improved patient participation in
treatment decision-making for cancer.
Keywords: Lung cancer, Patient information, Internet, Treatment decisionsBackground
Patients increasingly wish to participate in health care
decision-making [1-3]. For shared decision-making (SDM),
a process in which patients are expected to use information
in making well-informed decisions, their access to relevant
information is crucial. Clinicians are now encouraged to
integrate SDM into their routine clinical practice to sup-
port patients with cancer, and one study revealed that clini-
cians were generally positive with SDM [4]. Patients with* Correspondence: w.hopmans@vumc.nl
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unless otherwise stated.cancer frequently access the Internet as a source of infor-
mation [5-7], both in order to prepare for their first con-
sultation with a specialist, and subsequently for questions
arising following the consultation [8,9]. All these factors
support the provision of comprehensive web-based infor-
mation for patients.
However, online information may not always be ad-
equately tailored to a patient’s perspective, particularly
if professionals did not engage patient groups before
developing information. Consequently, the information
provided may fail to fulfil the specific information needs of
patients, who may vary in health literacy. Health literacy has
been defined as the degree to which individuals obtain,
process, understand, and communicate about health-relatedral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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sions [10]. Patients often have difficulties in compre-
hending the information provided, especially because
health literacy levels are inadequate in a large part of
the population [10,11].
Qualitative user testing can be used to develop informa-
tion that is tailored to a patient’s perspective, using ap-
proaches that are well established in disciplines such as
social sciences and marketing research [12]. Such user test-
ing can consist of different approaches such as prompting
patients to ‘think aloud’ while using online information,
asking probing questions about specific areas of informa-
tion, and/or asking semi-structured questions about infor-
mation needs and satisfaction [13-18]. These methods
allow patients to verbalize their thoughts about the infor-
mation while evaluating it, thereby enabling problems
such as understanding or finding information, to be iden-
tified and improved, accordingly.
The aim of the present study was to apply qualitative
user testing in order to develop and evaluate online pa-
tient information for a new website on stereotactic abla-
tive radiotherapy (SABR). SABR is a relatively recent,
guideline-specified non-invasive radiotherapy treatment
for patients with a stage I non-small cell lung cancer
(NSCLC) [19,20]. Patients are increasingly provided with
the option to undergo outpatient SABR, and should
ideally also be provided with information on conven-
tional radiotherapy and surgery. The aim of the website
was to provide information about this treatment, in order
to prepare patients to discuss treatment options with their
physician, and ultimately to make a treatment decision.
We considered this topic to provide a good opportunity
for developing tailored information to patients with differ-
ent levels of health literacy and educational levels.
This study focused on the following areas: (i) document
the information search behaviour of patients with an early
stage lung cancer prior to attending the first consultation
with a radiation oncologist, (ii) determine the comprehen-
sibility and usability of the information provided on the
new website, and (iii) study the patients’ evaluation of the
website. Our ultimate goal was to develop a patient-
centred website that is ready to be used by patients who
are eligible to undergo SABR.
Methods
Participants
Participants were recruited from new referrals for SABR to
the Radiation Oncology department of a large university
medical center, as well as their accompanying relatives.
The study protocol was approved by the institutional
Medical Ethic Committee (NTR 3243). Eligible patients
were provided with written information about the study
approximately one week prior to their first consultation,
and were approached at the outpatient radiation oncologyclinic by the treating physician and researcher (WH).
Eligible participants had to meet the following criteria:
(a) have a diagnosis of a stage I NSCLC, or be either a
relative or friend accompanying the patient, (b) be sched-
uled to undergo SABR, (c) be a Dutch-speaking adult,
(d) being able to communicate verbally, and (e) be willing
to sign an informed consent form. The study was con-
ducted between March 2012 and September 2014.
Study design
This study consisted of three phases, namely (1) the
website development, (2) a qualitative user test of the
prototype website and (3) an additional user test after a
redesign of the website. We included 18 participants in
phase 2, and nine participants in phase 3. Previous re-
search suggested that around 95% of usability problems
could be detected by including 15-20 participants [21].
However, as phase 3 focused on partially redesigned or
added sections of the website, and not on the complete
website, the chosen number of 9 participants was con-
sidered appropriate [22].
Phase 1: Website development
The prototype website was developed by a multidiscip-
linary research team, with assistance from a hospital in-
formation technology specialist. The research team was
composed of one health scientist (WH), two psycholo-
gists (OD, DT) and two radiation oncologists (SS, CH)
who held several consensus meetings about the content
and design of the website. We included information
about: (a) cancer in general and lung cancer, (b) details
of the SABR procedure, outcomes and side-effects, and
(c) references and links to related websites on cancer
and its treatment. The website development was guided
by patient information that had been approved by a hos-
pital Ethics committee for a phase III trial of Either
Surgery or Stereotactic Radiotherapy for Early Stage
Lung Cancer (ROSEL study, ClinicalTrials.gov Identi-
fier: NCT00687986). It was also guided by the usual
information provided to all SABR patients during their
first consultation at our institution with the radiation
oncologist. Text, photographs and videos were incor-
porated in order to account for the fact that patients
differ in their ability to process information in different
ways [23-25]. Furthermore, textual cancer-related infor-
mation with audiovisual information has been shown to
improve both website satisfaction and recall of online
cancer-related information in older lung cancer patients
[26]. We assessed the readability of the information pro-
vided using the Flesch Reading Ease score, which scores
the level of difficulty from 0 to 100 by using the length of
sentences and the number of polysyllabic words [27]. We
used modified formulas developed for the Dutch language
by Brouwer et al. [28]. The prototype website had a Flesh
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on the website was easily understandable by an average
fifth grader. Figure 1 shows an overview of the homepage
with subsections.
Phase 2: Qualitative user test prototype website
The qualitative user test consisted of several phases. Par-
ticipants provided written informed consent at the start
of the interview, which was audio-taped with their per-
mission. First, several semi-structured questions were
asked to establish the participants general search behav-
iour on the Internet, prior to being exposed to the new
website. Next, we assessed comprehensibility and usabil-
ity of the website using the ‘think aloud’ approach. The par-
ticipants viewed the website on a PC desktop computer in a
private room in the outpatients’ clinic, and were prompted
to ‘think aloud’ as they read and navigated through the web-
site. The instruction they received was as follows: “This is
the website http://www.stereotactische-bestraling.nl. You may
navigate through the website, just like you would do so at
home. It is important that you think aloud. That means that
you will try to tell me what you are thinking and doing and






Figure 1 Overview homepage with subsections.are clicking on, which choices you make or what stands out
for you and why”. During this phase, the researcher inter-
vened minimally, except to say “tell me what you are think-
ing” when the participants were quiet. Observations about
website use were recorded by scoring patients’ clicks on the
website and by drawing their search track. After participants
completed the website exploration, several probing ques-
tions were posed in order to determine if participants under-
stood the main topics of the website (e.g. ‘Can you tell me in
your own words what is meant by stereotactic radiotherapy?’;
“Can you tell me in your own words what these different side
effects mean?”). Finally, questions were asked in order to as-
sess participants’ own evaluations of the website (e.g. “What
do you think of the amount of information on the website?”;
“Did you miss a topic on the website?”; “What information
presented on the website did you find most useful?”; ‘Would
you recommend the website to others and if yes, to whom?”).
In order to be able to characterize the study population, we
collected demographic details (age, sex, educational level
and marital status) and assessed participants’ subjective
health literacy by asking three screening questions: “How
often do you have someone help you read hospital mate-
rials?”; “How confident are you filling out medical forms byn
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about your medical condition because of difficulty under-
standing written information?” [29,30] In addition, we col-
lected questions on Internet use.
Phase 3: Redesigning the website for additional user
testing
Following an analysis of participants’ verbalizations and
answers to our semi-structured questions, the website
content was revised with input from members of the
multidisciplinary research team, all of whom subsequently
reviewed and modified drafts of the new version. We then
invited three patients who had previously commented on
the first version of the website, together with six new par-
ticipants, to ‘think aloud’ while using the redesigned web-
site. This test phase used a similar approach as the first
user test, with specific attention paid toward participants’
reactions to the redesigned and newly added sections.
After the ‘thinking aloud’ part, where the participants
themselves navigated through the website, we posed spe-
cific questions to participants regarding the redesigned
sections (e.g. “What do you expect to read within the
subject of more information?”; “What do you expect to
read within the subject of information for relatives?”;
“You read about small cell lung cancer and non-small
cell lung cancer, can you tell me what this means to
you?”; “You read about normal radiation and stereotactic
ablative radiotherapy, can you tell me what this means to
you?”). In addition, in order to be able to characterize
the study population, we collected the same demo-
graphic details as in phase 2.
Data analysis
The original audio-tapes were transcribed verbatim by
the first author. Analysis consisted of various steps in
analysing qualitative data [31,32]. The first author read,
and re-read, all transcriptions and observation notes
from phase 2, to have an initial view about how patients’
used the information on the new website. Next, two re-
searchers (WH and OD) both independently analyzed
three transcriptions. Analysis consisted of coding tran-
scriptions into particular issues or ‘themes’ related to the
3 areas of patients’ information search prior to attending
the website, the problems in comprehensibility and us-
ability of the information, and how patients evaluated
the new website. The researchers next held two consen-
sus meetings to compare issues identified in the three
transcriptions of phase 2, and to further interpret these
issues. The first author analyzed the remaining tran-
scriptions, the final results of which were discussed with
the second author, before the recommendations were
formulated. Finally, the first author held meetings with
all members of the multidisciplinary team to discuss the
findings and the recommendations to redesign the website.In addition, data derived from phase 3 were analysed by
the first author and discussed with the second author to
see if there were still problems in usability and comprehen-
sibility. Next, these issues were discussed with members of
the multidisciplinary team. To illustrate the quantity of
how often the different issues were mentioned by our par-
ticipants, we used the guidelines of Sandelowski [33]. This
means that we used most, many, often, frequently and
generally when a theme was mentioned by more than
75% of participants, common and several when a theme
was brought up by 25% to 50% of participants, and few
and some were used when a theme was stated by less




The mean age of the 18 participants was 64.4 years
(SD = 6.2), with 6 participants being relatives of pa-
tients. Six patients had low health literacy levels, and 4
had low educational levels. Nine participants accessed
the Internet daily, of whom 3 indicated that they searched
the Internet daily on health-related information.
Phase 3
The mean age of the nine participants was 66.3 years
(SD = 12.1). Three participants were female, two had low
health literacy levels and two low educational levels. Of
these participants, seven stated that they accessed the
Internet daily, and one indicated a pattern of searching
daily for online health-related information (Table 1).
General information search before seeing the website
(phase 2)
Most participants indicated that they had accessed the
Internet for additional information on SABR, mainly fol-
lowing their visit with their lung physician when the
diagnosis of early stage lung cancer had been communi-
cated. These persons mentioned using search terms in
Google, such as stereotactic radiotherapy, stereotactic
radiation, radiation, stereotactic, lung radiation and 4D
radiation. Participants wanted to know the details of the
SABR treatment procedure, possible side-effects and dif-
ferences between SABR and conventional radiotherapy.
Similar information search behaviour was observed for
relatives. We noticed that this search for additional in-
formation was particularly apparent in those with lower
educational levels and low health literacy. These partici-
pants also explicitly mentioned that physicians did provide
them with information about the treatment procedure
and advantages, but that this information was relatively
limited and difficult to recollect during a stressful period.
As one participant stated:
Table 1 Sociodemograhic participant characteristics
Participant characteristics Number of participants
phase 2 (N = 18)
Number of “old” participants
phase 3 (N = 3)
Number of “new” participants
phase 3 (N = 6)
n % n % n %
Age < 50 1 5.6 0 0 1 16.7
50-64 6 33.3 0 0 1 16.7
65-80 11 61.1 3 100.0 4 66.7
Sex Male 10 55.6 2 66.7 4 66.7
Female 8 44.4 1 33.3 2 33.3
Education1 Low 4 22.2 0 0 2 33.3
Medium 8 44.4 1 50.0 3 50.0
High 6 33.3 1 50.0 1 16.7
Marital status Married 14 77.8 3 100.0 4 66.7
Living together 2 11.1 0 0 2 33.3
Widow 2 11.1 0 0 0 0
Health literacy2 Low 6 33.3 3 100.0 4 66.7
High 12 66.7 0 0 2 33.3
Internet use (Almost) every day 9 50.0 1 33.3 6 100.0
Once a week 6 33.3 1 33.3 0 0
Once a month 2 11.1 1 33.3 0 0
Never 1 5.6 0 0 0 0
Searching for health information
on the Internet
(Almost) every day 3 16.7 0 0 1 16.7
Once a week 2 11.1 0 0 2 33.3
Once a month 5 27.8 2 66.7 1 16.7
Never 8 44.4 1 33.3 2 33.3
1Low: primary school, lower level of secondary school or lower vocational training. Medium: higher level of secondary school, or intermediate vocational training.
High: higher vocational training or university.
2Question “Confident with forms” [29,30]: Low health literacy: patients answered: some of the time, a little of the time or none of the time. High health literacy:
patients answered: all of the time, most of the time.
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physician tells you something and then you feel down,
you have cancer. What do you remember afterwards?
At home, you can take a look again at the
information” (male, low health literacy, low education)
In addition, some participants stated that they sur-
veyed the Internet to explore whether the choice for
SABR was a good decision, in case a choice had been of-
fered between surgery and SABR.
“I wanted to read some independent information. I did
hear the whole story from my lung physician, but I
wanted to know whether I made a good decision”
(male, high health literacy, high education)
Qualitative user test prototype website (phase 2)
Treatment procedure
Participants appeared most interested in the webpages
‘which treatment options are available’ and ‘what is
stereotactic radiotherapy’, and indicated a preference formore detailed information on SABR as they did not
completely understand the procedure. The latter was
also illustrated by several questions posed about the
SABR procedure during the interview:
“All those X-rays, isn’t that bad for your body?” (female,
low health literacy, medium education)
“So when I undergo the treatment, I won’t feel pain?”
(male, low health literacy, low education)
Both lower- and higher educated and literate participants
found the information regarding the choice of number of
fractions needed for SABR delivery confusing. For example,
with respect to explaining the number of fractions, some
participants stated that the information on the website did
not match with the information from their clinician:
“My oncologist mentioned two to three times. On the
website, I read three to eight times” (male, high health
literacy, high education)
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husband is scheduled for 12 times” (female, relative of
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In addition, several participants appeared to be un-
aware of differences between conventional radiotherapy
and SABR treatment.
“Here I read that normally, radiation takes 3 to 8
times. So normally, that is the normal radiation, so
how many times is stereotactic radiation then?”(male,
high health literacy, high education)
Participant’s understanding of epidemiological evidence
All participants had difficulty understanding concepts re-
lating to the scientific evidence and clinical trials men-
tioned on the website. In this context, participants did not
know what “good results” meant, and many expected to
read more detailed and more exact information.
“This section doesn’t provide much information. Only
that the treatment works within patients who are fit to
undergo surgery. Furthermore, not much information
and the information provided isn’t very clear to me”
(female, low health literacy, medium education)
“Can’t they just say how many patients were treated
and what the results were?” (female, relative of
patient, high health literacy, high education)
Side-effect information
Some lower educated and less literate patients expressed
an interest in having more detailed and more concrete
side-effect information, e.g. how tired they would be
after treatment, and what was exactly meant by radiation
pneumonitis. For example:
“Perhaps you can add an extra link or something, so
you can click on it and read some extra information
about all these side-effects and what to expect” (female,
high health literacy, medium education)
“I would like to read more information about all these
side-effects. They have to provide an answer, not only
the names of the side-effects. How tired can you be,
and what about coughing? Everyone coughs sometimes”
(male, high health literacy, low education)
Risk concepts
On the prototype website, we described the risk of side-
effects after SABR treatment as follows: “Less than 5% of
all radiation patients will have side-effects”. Not all partici-
pants clearly understood this explanation. Several patients
thought that the 5% risk concerned the inconvenience of
getting one of these side-effects, e.g. radiation pneumonia.“There is a 5% chance to have a radiation
pneumonia” (female, relative of patient, high health
literacy, medium education)
“What the risks are in undergoing SABR treatment are
not very clear to me” (male, high health literacy, high
education)
Terminology
Some participants with lower educational level and low
health literacy struggled with the definitions of small cell
lung cancer and non-small cell lung cancer.
“There a two different types of lung cancer. Small cell
lung cancer and non-small cell lung cancer. So, that is
non-small cell lung cancer, so big and small? That is
not very clear to me” (male, low health literacy, low
education)
“So, what is small cell? What is smaller than small
cell”? (male, high health literacy, low education)
The use of the device names for radiation treatment,
such as “Truebeam”, “Novalis” and “Cyberknife” were
often incorrectly verbalised and participants mentioned
that these names “do not tell them much” and “should not
be mentioned on the website”. Furthermore, a few patients
also had difficulty in understanding technical terminology
of treatment preparation such as a 4 Dimensional com-
puted tomographic (4D-CT) scan, and also the fact that
lung tumors move.
“4D, that doesn’t say much to me. I can imagine that
you’ll be radiated from 4 different sites” (male, high
health literacy, high education)
“4D, so there will be 4 radiation beams on the tumor”
(male, high health literacy, high education)
“Tumor movement? I didn’t expect that the tumor
moved. I thought that the tumor was stuck on
something and that it can’t move” (female, low health
literacy, medium education)
Most participants also had difficulty in understanding
what was meant by “a good condition” in the context of
being fit to undergoing treatment and wanted to have
more concrete information.
“That condition. I suspect that my condition needs
to be checked first. What is meant by a good
condition? Does that mean that I can walk
regularly and feel good”? (male, high health
literacy, high education)
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frequently described the definition of SABR correctly.
Participants brought up terms like: very precise, dir-
ectly, saving surrounding tissues, localized, high in-
tension and involving the respiration, as illustrated by
these quotes:
“Stereotactic radiation is a very precise radiation
and focuses on a small tumor. The dose of the
radiation is also higher” (male, low health literacy,
high education)
“It is a very specific radiation. The radiation focuses
on the tumor without damaging the healthy tissues
(male, relative of patient, high health literacy, high
education)
“A highly intensive radiation, taking into account your
breath and limit the damage to the surrounding
tissues” (male, high health literacy, high education)
“That they only strongly radiate on the tumor itself
and less on the surrounding”(female, low health
literacy, low education)
Overall prototype website evaluation (phase 2)
When analysing the questions that were asked in order
to assess participants’ own evaluations of the website
(e.g., “What do you think of the amount of information
on the website?”; “Did you miss a topic on the website?”;
“What information presented on the website did you
find most useful?”; ‘Would you recommend the website
to others and if yes, to whom?”), the prototype website
was evaluated positively by participants. Participants
found the amount of information to be adequate and
that the information on the treatment itself and infor-
mation on side-effects were most useful:
“The information is clear and concise” (male, low
health literacy, medium education)
“How the treatment works. Before, I didn’t have a clue,
but now I do. Especially with these pictures and
videos, and how the treatment procedure is described”
(male, high health literacy, high education)
In addition, participants mentioned that they would
view the website again at home and that they would also
recommend it to others. Most participants felt that the
website adequately informed them about SABR, and some
indicated that they would have preferred to access the
website prior to their first consultation with the radiation
oncologist or lung physician, enabling them to ask fewer
questions and to save time.“We did ask questions about the radiotherapy itself.
How does it work, what is the procedure etc. If we
would have first looked at this website, we would have
already been informed. Maybe the physician would
then have asked, ‘do you have any questions’? Then I
would have answered: ‘we already visited the website,
it is all clear’” (male, high health literacy, medium
education)
Some participants mentioned that reading information
about the treatment itself, side-effects and results re-
duced their anxiety.
“The information about the tumor is very reassuring
and interesting. When I think of a tumor, I
immediately think of a little black devil. The
information here really dismantles that” (female,
relative of patient, high health literacy, medium
education)
The online information was seen as complementary to
the information provided by the radiation oncologist,
and led to the website information being trusted by par-
ticipants. Furthermore, some patients had a preference
for additional information on their role as patients, such
as on how to obtain a second opinion, on contacting pa-
tient organizations, and on where to go in case of ques-
tions. A final topic raised by some participants was that
they would prefer a website providing additional infor-
mation about surgery.
“I would prefer more information about the other
treatment option on the website as well. Then you
would have it all in one” (male, low health literacy,
high education)
“I would prefer a sort of checklist, with both
information about surgery and radiation. Then the
choice might be easier to make” (male, high health
literacy, high education)
Redesigning the website for additional user testing
(phase 3)
Table 2 summarizes several of the changes made to the
website, and Figure 2 displays an overview of the rede-
signed homepage with sections. The revised website in-
cluded more detailed information about the treatment
process, results and side-effects, including additional
photographs and videos. For example, we added an in-
formation video about the 4D-CT scan, and included a
table comparing features on both conventional radiation
and SABR. Potential side-effects of SABR were also ex-
plained more thoroughly, and the description of risk infor-
mation was reworded. We changed this description from
Table 2 Changes made to the website
Website section Prototype website Final website
About the disease Information about the incidence of lung cancer in the
Netherlands.
We added two web sources with information for patients:
- Cancer in the Netherlands, trend and prognoses
- Integral Cancer Centre, The Netherlands
What is cancer? Description of cell division and how lung cancer occurs. We added an information video titled: “What is cancer”.
http://www.youtube.com/watch?feature=player_embedded
&v=L2uF0qk1jck
What is lung cancer? Non-small cell lung cancer and small-cell lung cancer
are mentioned. Furthermore, the different stages are
explained.
We added information about the two types of lung cancer
and explained the differences more thoroughly:
“Small cell lung cancer is a fast growing type of lung cancer.
It spreads more quickly to the lymph nodes, and is therefore
almost always treated with chemotherapy or a combination
of chemotherapy and radiotherapy. Patients with small cell
lung cancer are not candidates for stereotactic ablative
radiotherapy”.
“Non-small cell lung cancer is the most common sub-type
of lung cancer. It usually grows and spreads more slowly
than small-cell lung cancer”.
Which treatment options
do I have?
Description of the different treatment options for an early
stage lung cancer (surgery and stereotactic ablative
radiotherapy) and information about the importance of
a good condition.
- We added information about the importance of being in a
good condition. - We mentioned that the condition is tested,
for example by a bicycle-test, to provide some meaning to
the term ‘good condition’.
What is stereotactic
ablative radiotherapy?
Description of stereotactic ablative radiotherapy (precision
radiation etc) and the treatment process.
- We added information about both stereotactic ablative
radiotherapy and conventional radiotherapy. A table was
added so that patients could easily see differences
between these two radiation approaches.
- We revised the text and described the treatment itself more
thoroughly, with added information about the treatment
team (radiotherapist etc).





Description of the radiation preparation, including a 4D-CT
scan, drawing marks on the body, x-rays being made etc.
- We added about a 4D-CT scans, including an information
video titled: “4D-CT scan and radiation”.
- We added information about the radiation preparation and
added two new photographs of marks/lines drawn on the
body surface to assist in positioning.
-Also added was a section with information about radiation
delivery, and described the whole process from arriving at
the hospital until going home after treatment.
Results Description of the results of SABR treatment - We revised this information for easier understanding by
patients: “Until now, this way of radiotherapy is particularly
done within patients who were not a candidate to undergo
surgery. This could be because they were not fit enough.
In such patients, good results have been achieved, and the
likelihood of being cured is the same as when a patient
undergoes an operation. As a result of these good results,
stereotactic radiotherapy is increasingly used in patients
who are a candidate to undergo surgery, but who declined
to undergo surgery. Reasons for the latter included an
aversion to possible side-effects of surgery, or because of
a patients preference for stereotactic radiotherapy”.
- We added references to different studies which had been
performed using stereotactic ablative radiotherapy.
Side-effects The different side-effects are mentioned as follows: Some
patients experience:
- We extended information about the potential side-effects.
For example:
Some discomfort lying in the machine: The couch of the
machine has a hard surface, which can make it
uncomfortable for patients.
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Table 2 Changes made to the website (Continued)
• Some discomfort lying in the machine Fatigue: Many patients experience tiredness, which may
partly be due to travelling to and from the hospital. To
minimize this, patients should plan for a less hectic schedule
during treatment.
• Fatigue
• Painful ribs after treatment
Etc.
Risk information was provided as follows: “During the
treatment itself hardly any side effects occur. Less than
5% of all patients experience these side effects”
The information on risks was presented differently: “At the
very most, 1 out of the 20 patients who undergo this
treatment, will have side-effects”.
More information This section provides information when patients still have
some questions about stereotactic radiotherapy after
reading the information on the website. Patients are
advised to contact their physician.
- We added information about obtaining a second opinion,
and included a link to a website with information about
these second opinions.
-We added an information video, titled: “Conversation with
your doctor”. http://www.youtube.com/watch?feature=
player_embedded&v=6Tlb36jni64
Information for relatives - -A new section was added to cater to the information needs
of relatives.





- We added a new section with frequently asked questions
during interviews, e.g.:
“Could the additional x-rays performed be bad for one’s
health?”
“Does the treatment hurt?”
“Do I remain radioactive following the treatment?”
About this website - - A new section was added with information about the aims
of the website.
- We added website links and references.
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have side-effects) to a proportion (e.g., 1 out of 20 patients
that undergo this treatment, suffers from side-effects). We
also included three new sections with “information for rel-
atives”, “frequently asked questions”, and “about this web-
site”, in response to the information needs of patients
(Table 2 and Figure 2). The redesigned website was tested
again among users. The information video on the 4D-CT
scan procedure, and the table comparing conventional ra-
diation therapy and SABR, were understood well and eval-
uated positively.
(Reaction to 4D-CT scan video): “Now you can im-
agine how you have to lay down and you can see the
radiation going through your body, right on the tumor
cell” (male, high health literacy, medium education)
(Reaction to comparing table): “Stereotactic radiation
is very precise, on the tumor cell itself, and you only
have to be here for a few times. This is not the case
with conventional radiation, which takes much longer
and causes more damage” (female, high health
literacy, medium education)However, the extra focus on conventional radiotherapy
led to some participants questioning why this form of
radiotherapy was not considered a treatment option for
them. Analysis of participants’ reactions to the reformu-
lated explanations of small cell lung cancer and non-
small cell lung cancer, as well as additional information
on side-effects, suggested that the explanations provided
on the website were comprehensible.
“Small cell lung cancer is the bad one, that goes very
fast. Then the cancer has spread through your whole
body. I have non-small cell lung cancer, that is still
good, it is still small, and it is treatable” (female, high
health literacy, high education)
“Radiation pneumonitis. Yes, that is because of the
radiation. It can damage your lung and then your
lung gets infected” (female, high health literacy,
medium education)
However, despite rewording of the text on risks (e.g., that
1 out of 20 patients that undergo this treatment, suffers













Figure 2 Overview redesigned homepage with subsections.
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understood by all participants:
“Well, that’s 20%. Personally, I would recommend to
describe 20%, but not everyone is good at mental
arithmetic” (male, high health literacy, low education)
“1 out of 20 patients? That is quite a lot. That is 20%”
(male, high health literacy, high education)
When asked about their expectations of the nature of
“more information” (e.g., this section provides informa-
tion when patients still have some questions about SABR
after reading the information on the website, patients
are advised to contact their physician), participants did
not always know what to expect:
“I’ve got no idea. Maybe more information about the
hospital itself?” (female, high health literacy, medium
education)
“I’ve got no clue, perhaps information about after
care?” (male, low health literacy, low education)This suggests that this section might better be reworded
on the website to provide it some meaning, for example
‘conversation with your doctor’.
The revised and expanded sections appeared clearer
for patients, and were considered useful as indicated by
the comments, for example:
(Reaction to the section “information for
relatives”): “That I can imagine what my partner
goes through. I’m the one with the cancer, but he is
also. He sympathizes, thinks along, stands by me,
complements me, and often he knows more than I
do” (female, high health literacy, medium
education)
Overall, the redesigned website was considered more
comprehensible and usable.
“The information is accessible, easy to understand and
my relatives can also benefit from this. So when I want
to explain something about the treatment, I can
recommend them to access the website” (male, low
health literacy, low education)
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combination of videos and text. Videos make it more
concrete because of the fact that you now know what
to expect and text is pleasant because it explains
everything briefly with additional background
information” (female, high health literacy, high
education)
Participants succeeded in navigating the website in a lo-
gical manner, and the majority identified no further areas
for improvement. However, one participant suggsted that
patient stories might prove a useful addition to the website.
None of the participants reported missing information.
“Did I miss anything? No, I don’t think so. It is clear,
looks good. I’m going to view the website again at
home. What was the name of the website again?”
(male, high health literacy, high education)
Discussion
Since its introduction in the early 1990’s, the growing
use of SABR for stage I NSCLC has resulted in improved
population-based survival rates [34,35]. As more patients
are now eligible to undergo SABR, we considered SABR
an ideal indication for developing online information tai-
lored to the patient’s perspective. Our study used qualita-
tive user testing in order to develop online information
about SABR, and a key finding was that our website cre-
ated by experts was not considered ideal by patients and
their relatives. Many participants wished to have different
information than what was provided initially on the web-
site, especially more detailed information about SABR and
side-effects. In addition, patients did not fully understand
the medical terminology used, or the information used to
describe the scientific evidence regarding SABR.
The participants’ felt a need for detailed and concrete
information that had not been provided on the initial
website. Specifically, participants wanted a step-by-step
description of details of the SABR treatment procedure
itself, as well as detailed information about the side-
effects of SABR. These finding are consistent with previ-
ous work which found that older cancer patients placed
‘treatment-related information’ most important [36]. Our
finding suggests that routine patient information now pro-
vided by thoracic oncologists may not be optimal.
To the best of our knowledge, no other studies have
been conducted on the information needs of patients fa-
cing a new treatment option for cancer. However, stud-
ies on more conventional treatment options showed that
information provided by clinicians about treatment op-
tions and outcomes is often considered to be insufficient
by patients [37-40]. In addition, even when clinicians
do provide extensive information, patients and rela-
tives may still want to review the information at home.The latter was explicitly stated by some of our partici-
pants with low health literacy and low educational levels.
Informing patients about a relevant website, both before
and after their first consultation seems essential in sup-
porting patients in asking specific questions, preparing
them for discussions with their clinicians and sharing
their concerns, as well as in supporting their treatment
decisions.
We identified problems in patients understanding of
the medical terminology provided, such as the definition
of NSCLC and terms like ‘4D-CT scan’, a finding re-
ported in earlier studies, for example, on the compre-
hension of both verbal and written patient information
[41-44]. A scheme developed to classify errors in lay
comprehension of medical information, identified ‘clin-
ical concepts’ and ‘terminology’ as essential categories of
lay errors in understanding medical documents [45]. As
clinicians do use these terms in their consultations, it
appears important to provide clear explanations of these
terms consistent in online communication. These find-
ings suggest that clinicians and health professionals
often overestimate patients’ health literacy and use med-
ical terms with the presumption that a patient under-
stands it [46,47]. Our qualitative assessment showed that
lay errors in comprehending web information can be
relatively easily identified and solved, for example by
providing extra explanations.
Another common problem identified concerns misun-
derstanding of information relating to the scientific evi-
dence with respect to treatment options. Patients have
difficulties in understanding information pertaining to
clinical research, and treatment risks and benefits are
particularly poorly understood [48]. Patients have par-
ticular trouble understanding risk information, which is
typically complex and abstract in nature [49,50], and
which impacts on patients’ comprehension, as shown in
our study, as well as by others [51,52]. Difficulty in under-
standing risk information may persist, even when informa-
tion is presented in accordance with current guidelines
[49]. Consequently, use of visual aids (i.e., icon array or
bar graph) may be necessary to improve understanding of
risk information [53].
One limitation of our study which must be acknowl-
edged is that our study population was already referred
to a department of Radiation Oncology. As such, our
conclusions may be less applicable to the larger popula-
tion of patients with early stage lung cancer, for example
those who may be receiving other treatment advise.
Conclusions
By using qualitative user testing, we identified problems
faced by participants in interpreting available online infor-
mation about SABR, an outpatient treatment for early-
stage lung cancer. Our study patients and their relatives
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http://www.biomedcentral.com/1472-6947/14/116desired information on areas that were not foreseen by
professionals who developed the website. These findings
indicate that a careful testing of websites among the targeted
patient groups is necessary in order to develop patient-
centred information that patients may use for treatment
decision-making.
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